 |
Recombinant Epstein-Barr virus gp350 glycoprotein vaccine |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention of post-transplantation lymphoproliferative disorders in pediatric recipients of solid-organ transplantation |
| USA Market Approval | USA |
| USA Designation Date | 2005-08-18 00:00:00 |
| Sponsor | Henogen S.A.;Rue des Professeurs Jenner et Brachet, 12, B-6041-Gosselies; |
